Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,181 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
MELANOCYTOMA OR JUXTAPAPILLARY MELANOMA?
Baartman BJ, Ahmad B, Srivastava S, Jones S, Singh AD. Baartman BJ, et al. Among authors: srivastava s. Retin Cases Brief Rep. 2019 Winter;13(1):15-17. doi: 10.1097/ICB.0000000000000520. Retin Cases Brief Rep. 2019. PMID: 28060135
A CASE REPORT OF CHRONIC ENDOPHTHALMITIS SECONDARY TO AQUAMICROBIUMterrae.
Venkat AG, Abraham JR, Bessette A, Karthik N, Baynes K, Lowder CY, Srivastava S. Venkat AG, et al. Among authors: srivastava s. Retin Cases Brief Rep. 2022 Jul 1;16(4):448-451. doi: 10.1097/ICB.0000000000001003. Epub 2020 Apr 28. Retin Cases Brief Rep. 2022. PMID: 32349062
Immunotherapy-Resistant Vitreoretinal Metastatic Melanoma.
Venkat A, Binkley EM, Srivastava S, Karthik N, Singh AD. Venkat A, et al. Among authors: srivastava s. Ocul Oncol Pathol. 2021 Mar;7(1):62-65. doi: 10.1159/000511187. Epub 2020 Nov 3. Ocul Oncol Pathol. 2021. PMID: 33796519 Free PMC article.
Primary central nervous system lymphoma: Inter-compartmental progression.
Raval V, Binkley E, Aronow ME, Valenzuela J, Peereboom DM, Wei W, Srivastava S, Davanzo J, Boldt HC, McGarrey MP, Papaliodis GN, Sobrin L, Kim IK, Vavvas DG, Eliott D, Nayak L, Dodds E, Marco Del Pont F, Singh AD. Raval V, et al. Among authors: srivastava s. EJHaem. 2022 Jan 20;3(2):362-370. doi: 10.1002/jha2.303. eCollection 2022 May. EJHaem. 2022. PMID: 35846050 Free PMC article.
A single-arm, investigator-initiated study of the efficacy, safety and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration, previously treated with ranibizumab or bevacizumab: 6-month interim analysis.
Singh RP, Srivastava S, Ehlers JP, Bedi R, Schachat AP, Kaiser PK. Singh RP, et al. Among authors: srivastava s. Br J Ophthalmol. 2014 Jun;98 Suppl 1(Suppl 1):i22-27. doi: 10.1136/bjophthalmol-2013-304798. Br J Ophthalmol. 2014. PMID: 24836866 Free PMC article. Clinical Trial.
Impact of initial visual acuity on anti-VEGF treatment outcomes in patients with macular oedema secondary to retinal vein occlusions in routine clinical practice.
Wai KM, Khan M, Srivastava S, Rachitskaya A, Silva FQ, Deasy R, Schachat AP, Babiuch A, Ehlers JP, Kaiser PK, Yuan A, Singh RP. Wai KM, et al. Among authors: srivastava s. Br J Ophthalmol. 2017 May;101(5):574-579. doi: 10.1136/bjophthalmol-2016-308727. Epub 2016 Aug 8. Br J Ophthalmol. 2017. PMID: 27503394
Intravitreal Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy: Outcomes from the Randomized RECOVERY Trial.
Wykoff CC, Nittala MG, Zhou B, Fan W, Velaga SB, Lampen SIR, Rusakevich AM, Ehlers JP, Babiuch A, Brown DM, Ip MS, Sadda SR; Intravitreal Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy Study Group. Wykoff CC, et al. Ophthalmol Retina. 2019 Dec;3(12):1076-1086. doi: 10.1016/j.oret.2019.07.011. Epub 2019 Jul 24. Ophthalmol Retina. 2019. PMID: 31542339 Clinical Trial.
6,181 results